GVS advice for cladribine (Mavenclad®) – extension of further conditions

van der Waal JM, Wijma S
Record ID 32018002698
Dutch
Details
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Other
Country: The Netherlands
MeSH Terms
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine
  • Immunosuppressive Agents
Contact
Organisation Name: The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address: Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name: Timon Sibma
Contact Email: TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.